Recent developments in medical research and health policy highlight breakthroughs in chronic disease management and administrative challenges in clinical settings.

New research suggests that allergies and autoimmune diseases share underlying immune dysfunction, including common inflammatory pathways and genetic susceptibilities.

Clinical trial results for the bivalent FGF21 analogue efruxifermin indicate a sustained improvement in fibrosis for patients with metabolic dysfunction-associated steatohepatitis.

UK healthcare unions, including the BMA and UNISON, have rejected a 2.4 percent pay rise proposal for doctors, warning that the increase is insufficient and could lead to staff attrition.

Nova Biomedical has issued a recall for StatStrip Glucose Hospital Meters due to a software issue involving barcode scanning that necessitates a corrective update.

The American College of Obstetricians and Gynecologists (ACOG) released updated guidance for managing menopause, placing a greater focus on sleep and mood alongside traditional vasomotor symptom treatment.

A randomized Italian trial demonstrated that performing endoscopic submucosal dissection (ESD) underwater improves procedural visibility and efficiency compared to gas-filled methods.

The MHRA has authorized plozasiran, an ApoC3 inhibitor injected quarterly, which significantly reduced triglyceride levels by approximately 80 percent in patients with a rare lipid disorder.

Medical experts emphasize that effectively managing difficult-to-treat rheumatoid arthritis requires distinguishing between inflammatory and noninflammatory patient phenotypes to guide therapy.